What's in Sinovac Life Sciences Co., Ltd.'s pipeline?

Sinovac Life Sciences Co., Ltd. has 7 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 3 in Phase 1.

Which companies overlap with Sinovac Life Sciences Co., Ltd.'s portfolio?

Top competitors by shared drug class: Biogen, Genentech, Inc., GlaxoSmithKline, Hoffmann-La Roche, Hospital Clinic of Barcelona.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sinovac-life-sciences-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Sinovac Life Sciences Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sinovac Life Sciences Co., Ltd. pipeline: 1 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Prevenar13®	Prevenar13®	marketed
Investigational tetanus vaccine, adsorbed	Investigational tetanus vaccine, adsorbed	phase 3	Toxoid vaccine	Tetanus toxin (tetanospasmin)	Immunology
Control tetanus vaccine, adsorbed	Control tetanus vaccine, adsorbed	phase 3	Inactivated bacterial toxoid vaccine	Tetanus toxin (tetanospasmin)	Immunology / Infectious Disease

Therapeutic area mix

Immunology · 1
Immunology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Biogen · 1 shared drug class
Genentech, Inc. · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Hospital Clinic of Barcelona · 1 shared drug class
Korea University Guro Hospital · 1 shared drug class
London School of Hygiene and Tropical Medicine · 1 shared drug class
National Institute of Allergy and Infectious Diseases (NIAID) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sinovac Life Sciences Co., Ltd.:

Cite this brief

Drug Landscape (2026). Sinovac Life Sciences Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sinovac-life-sciences-co-ltd. Accessed 2026-06-10.